Clinical Trials Browser

Unknown × Prednisone × Genitourinary × Clear all

NCT05223582 2023-12-08

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Phase 2 Unknown

Prostatic Neoplasms

NCT01949337 2023-09-28

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Phase 3 Unknown

1,311 enrolled 12 charts

Prostatic Neoplasms

NCT04869371 2022-12-29

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Phase 2 Unknown

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

NCT04356430 2022-12-16

Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT05167175 2022-10-25

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Phase 2 Unknown

Prostatic Neoplasms

NCT05188911 2022-01-12

Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

Neoplasm Metastasis, Prostatic Neoplasms

NCT05156450 2021-12-14

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms, Castration-Resistant

NCT03356912 2017-12-14

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Phase 2 Unknown

Prostatic Neoplasms

NCT01685125 2017-07-07

Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT02208583 2014-08-05

Molecular Phenotype Changes and Personalized Treatment for CRPC

Phase NA Unknown

Hormone Refractory Prostate Cancer

NCT00003633 2013-12-19

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Phase 1 Unknown

Prostatic Neoplasms